These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34229201)

  • 1. N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-β-lactamase-1.
    Gao H; Li JQ; Kang PW; Chigan JZ; Wang H; Liu L; Xu YS; Zhai L; Yang KW
    Bioorg Chem; 2021 Sep; 114():105138. PubMed ID: 34229201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.
    Liu L; Xu YS; Chigan JZ; Zhai L; Ding HH; Wu XR; Chen WY; Yang KW
    Bioorg Chem; 2022 Oct; 127():105928. PubMed ID: 35717802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.
    Li JQ; Gao H; Zhai L; Sun LY; Chen C; Chigan JZ; Ding HH; Yang KW
    Bioorg Med Chem; 2021 May; 38():116128. PubMed ID: 33862468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Ge Y; Kang PW; Li JQ; Gao H; Zhai L; Sun LY; Chen C; Yang KW
    J Antibiot (Tokyo); 2021 Sep; 74(9):574-579. PubMed ID: 34234284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.
    Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW
    Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors.
    Shaaban MM; Ragab HM; Akaji K; McGeary RP; Bekhit AA; Hussein WM; Kurz JL; Elwakil BH; Bekhit SA; Ibrahim TM; Mahran MA; Bekhit AA
    Bioorg Chem; 2020 Dec; 105():104386. PubMed ID: 33137556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H
    Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
    Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Acid Thioesters Exhibit Inhibitory Activity against B1-B3 Subclasses of Metallo-β-lactamases.
    Zhang YJ; Liu XL; Wang WM; Chen C; Zhao MH; Yang KW
    Chem Pharm Bull (Tokyo); 2019; 67(2):135-142. PubMed ID: 30713274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of hydroxamate as a promising scaffold dually inhibiting metallo- and serine-β-lactamases.
    Wu XR; Chen WY; Liu L; Yang KW
    Eur J Med Chem; 2024 Feb; 265():116055. PubMed ID: 38134748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
    Zhang J; Wang S; Wei Q; Guo Q; Bai Y; Yang S; Song F; Zhang L; Lei X
    Bioorg Med Chem; 2017 Oct; 25(19):5133-5141. PubMed ID: 28784300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.
    Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J
    Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxamic acid with benzenesulfonamide: An effective scaffold for the development of broad-spectrum metallo-β-lactamase inhibitors.
    Li JQ; Chen C; Yao M; Sun LY; Gao H; Chigan J; Yang KW
    Bioorg Chem; 2020 Dec; 105():104436. PubMed ID: 33171408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
    Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
    Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
    Guo Y; Yang Y; Xu X; Li L; Zhou Y; Jia G; Wei L; Yu Q; Wang J
    Eur J Med Chem; 2022 Mar; 231():114108. PubMed ID: 35101651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
    Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
    ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli.
    Li X; Zhao D; Zhao X; Cheng P; Li F; Sun J; Li Y; Bai J; Zhang X
    Eur J Med Chem; 2023 Mar; 250():115225. PubMed ID: 36870273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.
    Xiang Y; Chang YN; Ge Y; Kang JS; Zhang YL; Liu XL; Oelschlaeger P; Yang KW
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5225-5229. PubMed ID: 29122480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.
    Chen C; Liu Y; Zhang YJ; Ge Y; Lei JE; Yang KW
    Future Med Chem; 2019 Sep; 11(18):2381-2394. PubMed ID: 31544522
    [No Abstract]   [Full Text] [Related]  

  • 19. Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases.
    Ge Y; Xu LW; Liu Y; Sun LY; Gao H; Li JQ; Yang K
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel partially reversible NDM-1 inhibitors based on the naturally occurring houttuynin.
    Wang L; Liang Y; Luo P; Huang M; Wan Y
    Bioorg Chem; 2024 Jun; 147():107328. PubMed ID: 38583248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.